Chongqing Lummy Pharmaceutical (300006) - Total Assets

Latest as of September 2025: CN¥2.76 Billion CNY ≈ $404.21 Million USD

Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) holds total assets worth CN¥2.76 Billion CNY (≈ $404.21 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Chongqing Lummy Pharmaceutical - Total Assets Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's total assets have evolved over time, based on quarterly financial data. Also see market value of Chongqing Lummy Pharmaceutical for the company's overall valuation and market capitalisation.

Chongqing Lummy Pharmaceutical - Asset Composition Analysis

Current Asset Composition (December 2024)

Chongqing Lummy Pharmaceutical's total assets of CN¥2.76 Billion consist of 62.0% current assets and 38.0% non-current assets. Review 300006 total debt and obligations to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	37.5%
Accounts Receivable	CN¥453.42 Million	15.9%
Inventory	CN¥201.70 Million	7.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥217.27 Million	7.6%
Goodwill	CN¥44.95 Million	1.6%

Asset Composition Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Chongqing Lummy Pharmaceutical (300006) share price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Chongqing Lummy Pharmaceutical's current assets represent 62.0% of total assets in 2024, a decrease from 64.5% in 2006.
Cash Position: Cash and equivalents constituted 37.5% of total assets in 2024, up from 6.0% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 15.9% of total assets.

Chongqing Lummy Pharmaceutical Competitors by Total Assets

Key competitors of Chongqing Lummy Pharmaceutical based on total assets are shown below.

Company	Country	Total Assets
Pfizer Inc NYSE:PFE	USA	$201.13 Billion
AbbVie Inc NYSE:ABBV	USA	$136.46 Billion
Merck & Company Inc NYSE:MRK	USA	$129.80 Billion
AstraZeneca PLC MX:AZNN	Mexico	MX$114.07 Billion
Novartis AG ADR NYSE:NVS	USA	$122.03 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	China	CN¥2.89 Billion
Firebrick Pharma Ltd AU:FRE	Australia	AU$2.28 Million
Eli Lilly and Company SA:LILY34	Brazil	R$116.58 Billion

Chongqing Lummy Pharmaceutical - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.04	2.35	1.00
Quick Ratio	1.83	2.11	0.82
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥852.78 Million	CN¥1.06 Billion	CN¥-4.58 Million

Chongqing Lummy Pharmaceutical - Advanced Valuation Insights

This section examines the relationship between Chongqing Lummy Pharmaceutical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.93
Latest Market Cap to Assets Ratio	0.28
Asset Growth Rate (YoY)	-1.2%
Total Assets	CN¥2.86 Billion
Market Capitalization	$811.19 Million USD

Valuation Analysis

Below Book Valuation: The market values Chongqing Lummy Pharmaceutical's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Chongqing Lummy Pharmaceutical's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual total assets of Chongqing Lummy Pharmaceutical from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥2.86 Billion ≈ $417.89 Million	-1.21%
2023-12-31	CN¥2.89 Billion ≈ $423.03 Million	-5.37%
2022-12-31	CN¥3.05 Billion ≈ $447.04 Million	+4.38%
2021-12-31	CN¥2.93 Billion ≈ $428.28 Million	-7.02%
2020-12-31	CN¥3.15 Billion ≈ $460.62 Million	-10.10%
2019-12-31	CN¥3.50 Billion ≈ $512.37 Million	+11.48%
2018-12-31	CN¥3.14 Billion ≈ $459.59 Million	+14.61%
2017-12-31	CN¥2.74 Billion ≈ $401.00 Million	+10.32%
2016-12-31	CN¥2.48 Billion ≈ $363.50 Million	-19.94%
2015-12-31	CN¥3.10 Billion ≈ $454.03 Million	+38.28%
2014-12-31	CN¥2.24 Billion ≈ $328.35 Million	+2.83%
2013-12-31	CN¥2.18 Billion ≈ $319.31 Million	+53.27%
2012-12-31	CN¥1.42 Billion ≈ $208.34 Million	+31.71%
2011-12-31	CN¥1.08 Billion ≈ $158.18 Million	+22.28%
2010-12-31	CN¥884.01 Million ≈ $129.36 Million	+35.25%
2009-12-31	CN¥653.63 Million ≈ $95.65 Million	+143.38%
2008-12-31	CN¥268.56 Million ≈ $39.30 Million	+25.09%
2007-12-31	CN¥214.69 Million ≈ $31.42 Million	+71.61%
2006-12-31	CN¥125.10 Million ≈ $18.31 Million	--

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General

Market Cap

$811.19 Million

CN¥5.54 Billion CNY

Market Cap Rank

#9924 Global

#2596 in China

Share Price

CN¥5.25

Change (1 day)

+1.55%

52-Week Range

CN¥4.25 - CN¥6.58

All Time High

CN¥11.34